Program
masitinib
Also written as “Masitinib”, “masitinib (AB1010)” and “Masitinib (4.5)”.
Its studies are mostly in Multiple Sclerosis, Chronic Progressive · Alzheimer Disease · Amyotrophic Lateral Sclerosis · Asthma · Arthritis, Rheumatoid, led by AB Science.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AB Science | 384 open or running | phase 3since Nov 12, 2008 | Nov 12, 2008 | Dec 2027phase 3 · NCT03127267 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 23 studies since Nov 12, 2008.
- Oct 20, 2015Phase 3 study in Amyotrophic Lateral SclerosisNCT02588677 · 394 enrolled · Spain
- Nov 5, 2015Phase 3 study in Colorectal NeoplasmsNCT02605044 · 123 enrolled · France, Singapore, United Kingdom
- Apr 13, 2017Phase 3 study in Amyotrophic Lateral SclerosisNCT03127267 · 495 planned · United States, Belgium, Denmark and more
- Jun 3, 2018Phase 3 study in Colorectal Cancer MetastaticNCT03556956 · 219 enrolled · Czechia, France, Russian Federation and more
- Nov 30, 2018Phase 3 study in Metastatic Castrate Resistant Prostate CancerNCT03761225 · 714 enrolled · Canada, France, India and more
- Dec 4, 20182 phase 3 studiesNCT03766295, NCT03771040
- Apr 1, 2020Phase 3 study in Mastocytosis, SystemicNCT04333108 · 140 planned · France, Germany, Netherlands and more
- Nov 9, 2020Phase 2 study in COVID-19NCT04622865 · 200 enrolled · France
- Sep 16, 2021Phase 2 study in COVID-19NCT05047783 · 78 enrolled · France, Russian Federation, South Africa
- Dec 27, 2021Early phase 1 study in Healthy VolunteersNCT05200169 · 4 enrolled · United Kingdom
- Jun 28, 2022Phase 3 study in Multiple Sclerosis, Chronic ProgressiveNCT05441488 · 800 enrolled · France, Greece, Italy and more
- Jul 2, 2022Phase 2 study in Mast Cell Activation SyndromeNCT05449444 · 72 enrolled · United States, France
- Sep 29, 2022Phase 3 study in Alzheimer DiseaseNCT05564169 · 600 planned · France, Spain
- Sep 11, 2025Phase 3 study in Amyotrophic Lateral SclerosisNCT07174492 · 412 planned · Greece
Ahead
- Dec 2027Primary completion: phase 3 study in Amyotrophic Lateral SclerosisNCT03127267
- Dec 2028Primary completion: phase 3 study in Alzheimer DiseaseNCT05564169
- Dec 31, 2028Primary completion: phase 3 study in Amyotrophic Lateral SclerosisNCT07174492
TargetBeta
“Fibroblast growth factor receptor 3 inhibitor; Stem cell growth factor receptor inhibitor; Platelet-derived growth factor receptor inhibitor”ChEMBL 37, by rule
Studies
All 38 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07174492Amyotrophic Lateral Sclerosis · Greece | 3 | Not yet recruiting | Dec 31, 2028 | 412 |
| NCT05564169Alzheimer Disease · France, Spain | 3 | Not yet recruiting | Dec 2028 | 600 |
| NCT05449444Mast Cell Activation Syndrome · United States, France | 2 | UNKNOWN | Dec 31, 2024 | 72 |
| NCT05441488Multiple Sclerosis, Chronic Progressive · France, Greece, Italy and more | 3 | Suspended | Dec 2028 | 800 |
| NCT05200169Healthy Volunteers · United Kingdom | Early 1 | Completed | Sep 1, 2017 | 4 |
| NCT05047783COVID-19 · France, Russian Federation, South Africa | 2 | UNKNOWN | Dec 2023 | 78 |
| NCT04622865COVID-19 · France | 2 | UNKNOWN | Dec 2023 | 200 |
| NCT04333108Mastocytosis, Systemic · France, Germany, Netherlands and more | 3 | Recruiting | Dec 2024 | 140 |
| NCT03771040Asthma · Argentina, Malaysia, Peru and more | 3 | Completed | Sep 2020 | 347 |
| NCT03766295Pancreatic Neoplasms · Belgium, France, Greece and more | 3 | Completed | Dec 2020 | 377 |
| NCT03761225Metastatic Castrate Resistant Prostate Cancer · Canada, France, India and more | 3 | Completed | Dec 15, 2020 | 714 |
| NCT03556956Colorectal Cancer Metastatic · Czechia, France, Russian Federation and more | 3 | Completed | Dec 2020 | 219 |
| NCT03127267Amyotrophic Lateral Sclerosis · United States, Belgium, Denmark and more | 3 | Recruiting | Dec 2027 | 495 |
| NCT02605044Colorectal Neoplasms · France, Singapore, United Kingdom | 3 | Terminated | Dec 2017 | 123 |
| NCT02588677Amyotrophic Lateral Sclerosis · Spain | 3 | Completed | Dec 5, 2016 | 394 |
| NCT02490488Ovarian Neoplasms · Algeria, France, Russian Federation and more | 3 | Completed | Dec 2020 | 248 |
| NCT02009423Gastro-Intestinal Stromal Tumour | 3 | Terminated | Nov 2015 | 7 |
| NCT01872598Alzheimer Disease · Bulgaria, Greece, Poland and more | 3 | Completed | Dec 2020 | 721 |
| NCT01694277Gastrointestinal Stromal Tumors · United States, France, Italy and more | 3 | Completed | Dec 2020 | 258 |
| NCT01506336Gastro Intestinal Stromal Tumor · France | 2 | Completed | Sep 2011 | 44 |
| NCT01470131Multiple Myeloma · United States, France | 3 | Terminated | Jan 4, 2017 | 147 |
| NCT01450488Multiple Sclerosis | 2 | Completed | Jul 2007 | 35 |
| NCT01449162Asthma · Bulgaria, Czechia, France and more | 3 | Completed | Nov 2019 | 420 |
| NCT01433497Multiple Sclerosis, Chronic Progressive · Bulgaria, France, Germany and more | 3 | Completed | Sep 2019 | 656 |
| NCT01410695Arthritis, Rheumatoid · Czechia | 3 | Terminated | Oct 2015 | 324 |
| NCT01266369Mastocytosis | 2 | Completed | Nov 2007 | 21 |
| NCT01280565Melanoma · United States, Czechia, France and more | 3 | Terminated | Aug 2019 | 134 |
| NCT01045577Psoriasis | 2 | Completed | Jan 2006 | 25 |
| NCT00998751Gastro-intestinal Stromal Tumours · France | 2 | Completed | Jun 2013 | 30 |
| NCT00976118Alzheimer Disease | 2 | Completed | Jul 2008 | 34 |
| NCT00913432Arthritis, Rheumatoid | 2 | Completed | Jun 2009 | 20 |
| NCT00866138Multiple Myeloma · France | 2 | Completed | Jan 2011 | 24 |
| NCT00842270Asthma | 2 | Completed | Jul 2007 | 44 |
| NCT00831974Mastocytosis | 2 | Completed | Feb 2007 | 23 |
| NCT00831922Arthritis, Rheumatoid | 2 | Completed | Oct 2006 | 43 |
| NCT00814073Mastocytosis, Systemic · United States, France | 3 | Completed | Nov 2015 | 135 |
| NCT00812240Gastrointestinal Stromal Tumors · United States, France, Lebanon | 3 | Terminated | Jul 2018 | 335 |
| NCT00789633Pancreatic Neoplasms · United States, Czechia, France and more | 3 | Completed | Dec 23, 2011 | 353 |
How it is read
Names in the registry
- “Masitinib”, 19 entries
- “masitinib (AB1010)”, 6 entries
- “masitinib”, 6 entries
- “Masitinib (4.5)”, 4 entries
- “AB1010”, 3 entries
Conditions, from the studies’ own filings
- Multiple Sclerosis, Chronic Progressive, 3 studies
- Alzheimer Disease, 3 studies
- Amyotrophic Lateral Sclerosis, 3 studies
- Asthma, 3 studies
- Arthritis, Rheumatoid, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.